This application seeks competitive renewal of funding for the Yale Skin Diseases Research Core Center (YSDRCC), consisting of a multidisciplinary, collaborative, highly group of 74 investigators (52 established independent investigators) representing 24 different departments/divisions at this institution. These investigators share a commitment to advancing understanding of the etiology and pathogenesis of skin diseases through investigation of both normal and pathologic structure and function of skin. YSDRCC research activities center around two major themes: 1) Cutaneous Immunobiology/Immunopathology/vaccine development with emphasis on both normal T cell : skin interactions as well as those interactions in diseases including atopic and contact dermatitis, lupus erythematosus, scleroderma, cutaneous T cell lymphoma and bacterial (strep, Borrelia), papillomavirus and helminth infections; and 2) Epidermal Biology/Photobiology including studies of normal keratinocyte, keratinocyte/mesenchymal interactions, gene therapy and carcinoma, as well as of normal melanocytes and melanoma. Three Core units (Scid Mouse : Human Xenograft; Cell Culture; and Tissue Acquisition & Analysis) have been established to provide reagents and/or services to multiple YSDRCC investigators. The YSDRCC Pilot/Feasibility Program should continue to enhance the development of new interdisciplinary skin-related investigation by preferentially funding projects involving substantive multidisciplinary collaboration between investigators with complementary interests. The YSDRCC Enrichment Program should continue to provide numerous opportunities for developing new institutional and national collaborative studies. These component parts should each contribute to achieving the YSDRCC's continuing long range goal of creating an environment capable of greatly amplifying understanding of basic cutaneous biology and of a broad variety of skin diseases. To achieve that goal, the YSDRCC's continuing aims are to: 1) stimulate new multidisciplinary interactions; 2) stimulate new investigators to become involved in one or more areas of YSDRCC research; 3) capitalize on potentially important and innovative research opportunities via interdisciplinary pilot/feasibility studies; 4) organize time-consuming techniques, services and/or expensive reagents into cost-efficient core facilities used by multiple investigators; 5) provide a rich training environment; and 6) foster national and international collaborations. A new YSDRCC specific aim will be to facilitate the expansion of imaging capabilities at Yale to include multimodality imaging of skin in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR041942-14
Application #
7214206
Study Section
Special Emphasis Panel (ZAR1-AAA-G (J1))
Program Officer
Lapham, Cheryl K
Project Start
1992-09-30
Project End
2009-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
14
Fiscal Year
2007
Total Cost
$635,034
Indirect Cost
Name
Yale University
Department
Dermatology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Dainichi, Teruki; Hayden, Matthew S; Park, Sung-Gyoo et al. (2016) PDK1 Is a Regulator of Epidermal Differentiation that Activates and Organizes Asymmetric Cell Division. Cell Rep 15:1615-23
Askenase, Phillip W; Bryniarski, Krzysztof; Paliwal, Vipin et al. (2015) A subset of AID-dependent B-1a cells initiates hypersensitivity and pneumococcal pneumonia resistance. Ann N Y Acad Sci 1362:200-14
Clark, Paul R; Jensen, Todd J; Kluger, Martin S et al. (2011) MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 18:102-17
Kwong, Bernice Y; Roberts, Scott J; Silberzahn, Tobias et al. (2010) Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol 130:1726-36
Radtke, Christine; Vogt, Peter M; Devor, Marshall et al. (2010) Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain 148:94-102
Kirkiles-Smith, Nancy C; Harding, Martha J; Shepherd, Benjamin R et al. (2009) Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 87:189-97
Koga, Yasuo; Pelizzola, Mattia; Cheng, Elaine et al. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 19:1462-70
Yates, Kristin E; Korbel, Gregory A; Shtutman, Michael et al. (2008) Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 7:609-21
Pelizzola, Mattia; Koga, Yasuo; Urban, Alexander Eckehart et al. (2008) MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res 18:1652-9
Shen, Xiaoyan; Berger, Carole L; Tigelaar, Robert et al. (2008) Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading. Immunol Invest 37:798-821

Showing the most recent 10 out of 97 publications